Geor­gia law­mak­ers send let­ter to FDA over con­tin­ued can­cer drug short­age

Sen. Raphael Warnock (D-GA) and eight oth­er Geor­gia law­mak­ers on Thurs­day asked the FDA for more trans­paren­cy over the short­age of can­cer drugs like cis­platin and car­bo­platin.

Cis­platin, a stan­dard treat­ment for var­i­ous types of can­cer, has been in short­age since Feb­ru­ary. This has cas­cad­ed to oth­er can­cer drugs, such as car­bo­platin, which is al­so in short sup­ply.

The short­age stems from an FDA in­spec­tion in 2022 that led to the shut­down of In­tas Phar­ma­ceu­ti­cals’ man­u­fac­tur­ing plant in Ahmed­abad, In­dia. In­tas sup­plies half of the cis­platin in the US mar­ket. An­oth­er in­spec­tion of the same plant in May by the FDA re­vealed mul­ti­ple clean­ing and da­ta in­frac­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER